Results 111 to 120 of about 110,455,116 (191)
Argininosuccinate synthetase 1 (ASS1) regulates the provision of L‐arginine to nitric oxide synthase 3 (NOS3). Previous studies demonstrated that ASS1 and NOS3 expressions were enhanced by laminar shear stress (LSS), and ASS1 but not NOS3 expression was suppressed by endothelial cell senescence, so that the impaired NO production in senescent cells ...
Yong Chool Boo, Gyeong In Mun
openaire +1 more source
Comparison of two enzymes with similar substrate binding sites.
The proteins involved are Serine racemase from Schizosaccharomyces pombe (2zpu, left) and Argininosuccinate synthetase from Thermus thermophilus (1kor, right).
Pier Federico Gherardini (90873) +2 more
core +1 more source
Early prediction of phenotypic severity in Citrullinemia Type 1
Objective Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn screening. The clinical spectrum is highly variable including individuals with lethal hyperammonemic encephalopathy in the newborn
Matthias Zielonka +9 more
doaj +1 more source
Context: New biomarkers are needed in acetaminophen (APAP) hepatotoxicity. Plasma argininosuccinate synthetase (ASS) is a promising candidate. Objective: Characterize ASS in APAP hepatotoxicity. Methods: ASS was measured in plasma from rodents and humans
McGill, Mitchell R. +8 more
core +1 more source
精氨酸琥珀酸合成酶(Argininosuccinatesynthetase1,Ass1)能够催化瓜氨酸(L-Citrulline)和天冬氨酸(L-Aspartate)形成精氨琥珀酸,然后在精氨琥珀酸裂解酶(Argininosuccinatelyase,Asl)的作用下,生成精氨酸(L-Arginine)和延胡索酸。由于Asl的表达量恒定,因此Ass1是生成精氨酸的限速酶。本实验利用原位杂交和Real-timePCR检测了Ass1和Asl在围着床期小鼠子宫中的表达 ...
黄祝
core
Purpose: To report a 15 year old girl with citrullinemia type 1 and 2 accompanied by neurologic signs and symptoms and a novel ocular complaint in cornea like tyrosinemia type 2.
Davoud Amirkashani +5 more
doaj +1 more source
Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene
Citrullinemia type I is an autosomal recessive disorder that is caused by a deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS1). Deficiency of ASS1 shows various clinical manifestations encompassing severely affected patients with ...
Engel, K +5 more
core +1 more source
In the urea cycle the “toxin” ammonium (NH4+) is converted to non-toxic urea by five consecutive enzymatic reactions in the liver. In hepatocytes, the rate-limiting, ATP-dependent enzyme carbamoyl phosphate synthetase 1 (CPS1), which is allosterically ...
Matthias Gautschi (2608306) +7 more
core +1 more source
Circadian rhythm disruption (CRD) exacerbates epileptic seizures, yet the underlying molecular mechanisms remain unclear. Using a pentylenetetrazol (PTZ) kindling rat model combined with continuous light exposure, we found that CRD significantly ...
Fanqi Yu, Jia He, Yan Chen, Yulan Zhu
doaj +1 more source
peer reviewedThe enzyme argininosuccinate synthetase (ASS) is the rate limiting enzyme in the metabolic pathway leading from L-citrulline to L-arginine, the physiological substrate of all isoforms of nitric oxide synthases (NOS).
Feinstein, Douglas L. +5 more
core +1 more source

